P&T COMMUNITY
 
MediMedia Managed Markets
Our
Other
Journal
Managed Care magazine
P&T Community, The Online Resource for P&T Decision Makers
Login / Register
Join Us  Facebook  Twitter  Linked In
About P&T Journal
Contacts:
Editorial: Sonja Sherritze, Editor
Advertising: Maureen Dwyer Liberti,
    Vice President, Group Publisher

Production: Mary Ellen Curry,
    Director of Production Services

Circulation: Jackie Ott, Circulation Manager


Statement of Purpose
Guidelines for Authors
Masthead
Editorial Board
Reprints


Recent Issues

December 2012

Features

Health Care & Law

Transitions of Care

Pitfalls and Recommendations

Medication errors, with methotrexate in particular, are all too common — especially when patients are moved from one site of care to another. The authors discuss ways to improve appropriate medication use during patient transitions.
James O’Donnell, PharmD, MS; and F. Randy Vogenberg, RPh, PhD

Management of Type-2 Diabetes Mellitus in Adults

Focus on Individualizing Non-Insulin Therapies

Successful management of hyperglycemia may involve glucose and non-glucose therapies, non-drug approaches, and non-insulin agents. Treatment should be tailored to each patient, with an emphasis on safety.
Luigi Brunetti, PharmD, MPH, BCPS, CGP; and Julie Kalabalik, PharmD, BCPS

Sitagliptin/Metformin (Janumet) as Combination Therapy In the Treatment of Type-2 Diabetes Mellitus

Used together, sitagliptin (Januvia) and metformin (Glucophage) help to improve glycemic levels in diabetic patients, suggesting a synergy between the agents. However, the cost of sitagliptin and the need for more data may restrict its use. More studies are needed to assess the effects of long-term sitagliptin and to determine its role in combination therapy.
Erin L. St. Onge, PharmD; Shannon Miller, PharmD; and Elizabeth Clements, PharmD

Meeting Highlights

Transcatheter Cardiovascular Therapeutics 2012

Topics include comparisons of bivalirudin (Angiomax) and unfractionated heparin in reducing bleeding, prasugrel (Effient) and clopidogrel (Plavix) in acute myocardial infarction, aspirin for critical limb ischemia, and mobilized CD34+ cells for angina.
Walter Alexander

Thank You To Our 2012 Reviewers

Departments

Medication Errors

Avoiding Confusion With Alphanumeric Characters

Matthew Grissinger, RPh, FASCP

Prescription: Washington

‘Stage 2’ Incentive Rule for Electronic Records Highlights Importance of Hospital Pharmacy Data

Republicans Say Requirements for Incentives Are Set Too Low

Stephen Barlas

New Drugs/Drug News/New Medical Devices

FDA approvals, drug indications, and updates

Pharmaceutical Approval Update

Marvin M. Goldenberg, PhD, RPh, MS

Drug Forecast

Vismodegib (Erivedge) For Advanced Basal Cell Carcinoma

Chris Fellner